Recently, studies that treated non-alcoholic fatty liver disease (NAFLD) showed that the hepatic expression of iNOS was markedly increased in HFD-fed mice [40,93]. The gene discussed is NOS2; the disease is metabolic dysfunction-associated steatotic liver disease.